Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Serum Biomarkers for Early Detection of Hepatocellular Carcinoma Associated with HCV Infection in Egyptian Patients

  • Zekri, Abdel-Rahman (Virology and Immunolgy Unit, Cancer Biology Department, National Cancer Institute) ;
  • Youssef, Amira Salah El-Din (Virology and Immunolgy Unit, Cancer Biology Department, National Cancer Institute) ;
  • Bakr, Yasser Mabrouk (Virology and Immunolgy Unit, Cancer Biology Department, National Cancer Institute) ;
  • Gabr, Reham Mohamed (Virology and Immunolgy Unit, Cancer Biology Department, National Cancer Institute) ;
  • El-Rouby, Mahmoud Nour El-Din (Virology and Immunolgy Unit, Cancer Biology Department, National Cancer Institute) ;
  • Hammad, Ibtisam (Botany and Microbiology Department, Faculty of Science, Helwan University) ;
  • Ahmed, Entsar Abd El-Monaem (Botany and Microbiology Department, Faculty of Science, Helwan University) ;
  • Marzouk, Hanan Abd El-Haleem (Department of Endemic Medicine and Hepatology, Faculty of Medicine, Cairo University) ;
  • Nabil, Mohammed Mahmoud (Department of Endemic Medicine and Hepatology, Faculty of Medicine, Cairo University) ;
  • Hamed, Hanan Abd El-Hafez (Department of Endemic Medicine and Hepatology, Faculty of Medicine, Cairo University) ;
  • Aly, Yasser Hamada Ahmed (Department of Endemic Medicine and Hepatology, Faculty of Medicine, Cairo University) ;
  • Zachariah, Khaled S. (Department of Endemic Medicine and Hepatology, Faculty of Medicine, Cairo University) ;
  • Esmat, Gamal (Department of Endemic Medicine and Hepatology, Faculty of Medicine, Cairo University)
  • Published : 2015.03.04
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Early detection of hepatocellular carcinoma using serological markers with better sensitivity and specificity than alpha fetoprotein (AFP) is needed. Aims: The aim of this study was to evaluate the diagnostic value of serum sICAM-1, ${\beta}$-catenin, IL-8, proteasome and sTNFR-II in early detection of HCC. Materials and Methods: Serum levels of IL-8, sICAM-1, sTNFR-II, proteasome and ${\beta}$-catenin were measured by ELISA assay in 479 serum samples from 192 patients with HCC, 96 patients with liver cirrhosis (LC), 96 patients with chronic hepatitis C (CHC) and 95 healthy controls. Results: Serum levels of proteasome, sICAM-1, ${\beta}$-catenin and ${\alpha}FP$ were significantly elevated in HCC group compared to other groups (P-value<0.001), where serum level of IL-8 was significantly elevated in the LC and HCC groups compared to CHC and control groups (P-value <0.001), while no significant difference was noticed in patients with HCC and LC (P-value=0.09). Serum level of sTNFR-II was significantly elevated in patients with LC compared to HCC, CHC and control groups (P-value <0.001); also it was significantly higher in HCC compared to CHC and control groups (P-value <0.001). ROC curve analysis of the studied markers between HCC and other groups revealed that the serum level of proteasome had sensitivity of 75.9% and specificity of 73.4% at a cut-off value of $0.32{\mu}g/ml$ with AUC 0.803 sICAM-1 at cut off value of 778ng/ml, the sensitivity was 75.8% and the specificity was 71.8% with AUC 0.776. ${\beta}$-catenin had sensitivity and specificity of 70% and 68.6% respectively at a cut off value of 8.75ng/ml with an AUC of 0.729. sTNFR-II showed sensitivity of 86.3% and specificity of 51.8% at a cut off value of 6239.5pg/ml with an AUC of 0.722. IL-8 had sensitivity of 70.4% and specificity of 52.3% at a cut off value of 51.5pg/ml with AUC 0.631. Conclusions: Our data supported the role of proteasome, sICAM-1, sTNFR-II and ${\beta}$-catenin in early detection of HCC. Also, using this panel of serological markers in combination with ${\alpha}FP$ may offer improved diagnostic performance over ${\alpha}FP$ alone in the early detection of HCC.

Keywords

References

  1. Aberle H, Schwartz H and Kemler H (1996). Cadherin–catenin complex: protein interactions and their implications for cadherin function. J Cell Biochem, 61, 514-523. https://doi.org/10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R
  2. Adler KB, Fischer BM, Wright D T, et al (1994).Interactions between respiratory epithelial cells and cytokines: Relationships to lung inflammation. Ann NY Acad Sci, 725, 128-45.
  3. Albekairy A, Alkatheri A, and Mansour M (2013). Inhibition of ubiquitin-proteasome pathway: A possible treatment of hepatocellular carcinoma. IJMMS, 5, 312-19.
  4. Bernier AJ, Zhang J, Lillehoj E, et al (2011). Non-cysteine linked MUC1 cytoplasmic dimmers are required for Src recruitment and ICAM-1 binding induced cell invasion. Mol Cancer, 10, 93. https://doi.org/10.1186/1476-4598-10-93
  5. Bradley JR (2008). TNF-mediated inflammatory disease. J Pathol, 214, 149-60. https://doi.org/10.1002/path.2287
  6. Chumakov PM (2007). Versatile functions of p53 protein in multicellular organisms. Biochemistry, 72, 1399-421.
  7. Clevers H (2006). Wnt/$\beta$-catenin signaling in development and disease. Cell, 127, 469-80. https://doi.org/10.1016/j.cell.2006.10.018
  8. Diez-Ruiz A, Tilz GP, Zangerle R, et al (1995). Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol, 54, 1-8.
  9. El-Zanaty F, Way A (2008). Egypt Demographic and Health Survey (Egyptian Ministry of Health, El-Zanaty and Associates and Macro International, 2009).
  10. Gad A, Tanka E, Matsumoto A, et al (2005). Ethnicity affects the diagnostic validity of alpha-fetoprotein in hepatocellular carcinoma. Asia Pac J Clin Oncol, 1, 64-70. https://doi.org/10.1111/j.1743-7563.2005.00017.x
  11. Gao J, Xie L, Yang W, et al (2012). Risk factors of hepatocellular carcinoma - current status and perspectives. Asian Pac J Cancer Prev, 13, 743-52. https://doi.org/10.7314/APJCP.2012.13.3.743
  12. GLOBOCAN 2008 database (version 1.2). Available online: http://globocan.iarc.fr
  13. Guan C-N, Chen X-M, Lou H-Q, et al (2012). Clinical significance of axin and $\beta$-catenin protein expression in primary hepatocellular carcinomas. Asian Pac J Cancer Prev, 13, 677-81. https://doi.org/10.7314/APJCP.2012.13.2.677
  14. Henry L, Lavabre-Bertrand T, Vercambre L, et al (2009). Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis. Gut, 58, 833-8. https://doi.org/10.1136/gut.2008.157016
  15. Higashitsuji H, Itoh K, Sakurai T, et al (2005). The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cell, 8, 75-87. https://doi.org/10.1016/j.ccr.2005.06.006
  16. Hiotis SP, Rahbari NN, Villanueva GA, et al (2012). Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma. BMC Gastroenterol, , 64.
  17. Hyodo I, Jinno K, Tanimizu M, et al (1993). Detection of circulating intercellular adhesion molecule-1 in hepatocellular carcinoma. Int J Cancer, 55, 775-9. https://doi.org/10.1002/ijc.2910550514
  18. Kanayama H, Tanaka K, Aki M, et al (1991).Changes in expressions of proteasome and ubiquitin genes inhuman renal cancer cells. Cancer Res, 51, 6677-85.
  19. Kumatori A, Tanaka K, Inamura N, et al (1990). Abnormally high expression of proteasomes in human leukemic cells. Proc Natl Acad Sci USA, 87, 7071-5. https://doi.org/10.1073/pnas.87.18.7071
  20. Laurent-Puig P, Zucman-Rossi J (2006). Genetics of hepatocellular tumors. Oncogene, 25, 3778-86. https://doi.org/10.1038/sj.onc.1209547
  21. Lawrence, T. (2009). The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harbor Perspectives in Biology, 1, 1651. https://doi.org/10.1101/cshperspect.a001651
  22. Lawson C, Wolf S (2009). ICAM-1 signaling in endothelial cells. Pharmacol Rep, 61, 22-32. https://doi.org/10.1016/S1734-1140(09)70004-0
  23. Li P, Cao Y, Li Y, et al (2014). Expression of Wnt-5a and $\beta$-catenin in primary hepatocellular carcinoma. Int J Clin Exp Pathol, 7, 3190-5.
  24. Li P, Cao Y, Li Y, et al (2014). Expression of Wnt-5a and $\beta$-catenin in primary hepatocellular carcinoma. Int J Clin Exp Pathol, 7, 3190-5.
  25. Mittal A, Sathian B, Chandrashekharan N, et al (2008). Diagnostic significance of alpha fetoprotein in carcinomas of liver and biliary tract - a comparative study from western region of nepal. Asian Pac J Cancer Prev, 12, 3475-8.
  26. Moelants E, Mortier A, Van Damme J, et al (2013). Regulation of TNF-$\alpha$ with a focus on rheumatoid arthritis. Immunol Cell Biol, 91, 393-401. https://doi.org/10.1038/icb.2013.15
  27. Mohamed AA, Saad A, Saad S, et al (2014). Role of Intercellular adhesion molecules as tumor marker for detection of Hepatocellular carcinoma. IJAR, 2, 705-13. https://doi.org/10.16965/ijar.2014.531
  28. Morin PJ, Sparks AB, Korinek V, et al (1997). Activation of $\beta$-catenin-Tcf signaling in colon cancer by mutation in $\beta$-catenin or APC. Science, 275, 1787-90. https://doi.org/10.1126/science.275.5307.1787
  29. Moriyama M, Matsumura H, Shioda J, et al (2006). Measurement of human intercellular adhesion molecule 1 in the blood is useful for predicting the occurrence of hepatocellular carcinomas from chronic hepatitis C and liver cirrhosis. Intervirology, 49, 327-38. https://doi.org/10.1159/000095152
  30. Moriyama M, Matsumura H, Shioda J, et al (2006). Measurement of human intercellular adhesion molecule 1 in the blood is useful for predicting the occurrence of hepatocellular carcinomas from chronic hepatitis C and liver cirrhosis. Intervirology, 49, 327-38. https://doi.org/10.1159/000095152
  31. Rizk NM and Derbala MF (2012). Genetic polymorphisms of ICAM 1 and IL28 as predictors of liver fibrosis severity and viral clearance in hepatitis C genotype 4. Clin Res Hepatol Gastroenterol, 5, 259-8.
  32. Rothe J, Gehr G, Loetscher H, et al (1992).Tumor necrosis factor receptors-structure and function. Immunol Res, 11, 81-90. https://doi.org/10.1007/BF02918612
  33. Satoh S, Daigo Y, Furukawa Y, et al (2000). AXIN1 mutation in hepatocellular carcinomas and growth supression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet, 24, 245-50. https://doi.org/10.1038/73448
  34. Shimizu Y, Minemura M, Tsukishiro T, et al (1995). Serum concentration of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis. Hepatology, 22, 525-531.
  35. Sorokin AV, Kim ER and Ovchinnikov LP (2009). Proteasome system of protein degradation and processing. Biochemistry, 74, 1411-42.
  36. Waugh DJ and Wilson C (2008).The Interleukin-8 Pathway in Cancer. Clin Cancer Res, 14, 6735-41 . https://doi.org/10.1158/1078-0432.CCR-07-4843
  37. Yamashita T, Honda M and Kaneko S (2011). Molecular mechanisms of hepatocarcinogenesis in chronic hepatitis C virus infection. J Gastroenterol Hepatol, 26, 960-4. https://doi.org/10.1111/j.1440-1746.2011.06723.x
  38. A-R N, El-Din H M, BahnassyAA, et al (2010). Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4. Comp Hepatol, 9, 1. https://doi.org/10.1186/1476-5926-9-1
  39. Zekri A-RN, Bahnassy AA, Alam El-Din HM, et al (2011). Serum levels of $\beta$-catenin as a potential marker for genotype 4/hepatitis C-associated hepatocellular carcinoma. Oncol Rep, 26, 825-31.
  40. Zekri AR, Bahnassy AA, Abdel-Wahab SA, et al (2009). Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4. J Gastroenterol Hepatol, 24, 416-28. https://doi.org/10.1111/j.1440-1746.2008.05699.x
  41. Zekri AR, Bahnassy AA, Abdel-Wahab SA, et al (2009). Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4. J Gastroenterol Hepatol, 24, 416-28. https://doi.org/10.1111/j.1440-1746.2008.05699.x
  42. Zimmermann H W, Seidler S, Gassler N, et al (2011). Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PloS One, 6, 21381. https://doi.org/10.1371/journal.pone.0021381

Cited by

  1. Implications of Sex Hormone Receptor Gene Expression in the Predominance of Hepatocellular Carcinoma in Males: Role of Natural Products vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.4949
  2. Evaluation of trail receptor 1 (DR4) polymorphisms C626G and A683C as risk factors of hepatocellular carcinoma pp.01466615, 2017, https://doi.org/10.1002/jmv.24964
  3. Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients pp.1179-2000, 2017, https://doi.org/10.1007/s40291-017-0307-7
  4. Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions vol.24, pp.11, 2018, https://doi.org/10.3748/wjg.v24.i11.1228
  5. Daclatasvir and Sofosbuvir Therapy Enhance Monocyte Phenotypic Changes in Naive Chronic Hepatitis C Patients: A Prospective Cohort Study vol.2019, pp.1687-7098, 2019, https://doi.org/10.1155/2019/9469567